United States · FDA National Drug Code directory
Stridex Maximum
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10157-1006_43180c64-d273-49ad-82ec-09159af7d849
- Product NDC
- 10157-1006
- Form
- LIQUID
- Composition / generic term
- SALICYLIC ACID
- Labeler
- Blistex Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20121201
- Source listing expiry
- 20261231
Source-listed ingredients
- SALICYLIC ACID — 2 g/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 JAR in 1 CARTON (10157-1006-1) / 55 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR · 10157-1006-1
- 1 JAR in 1 CARTON (10157-1006-2) / 90 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR · 10157-1006-2
- 1 JAR in 1 CARTON (10157-1006-3) / 70 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR · 10157-1006-3
- 1 JAR in 1 CARTON (10157-1006-4) / 110 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR · 10157-1006-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →